Pulse Biosciences, Inc., a clinical-stage medical technology company, develops therapeutic tissue treatment platform based on its proprietary nano-pulse stimulation (NPS) technology. Its NPS is a non-thermal, precise, and focal drug-free tissue treatment technology that initiates cell death within treated tissue used in oncology, dermatology/aesthetics, minimally invasive, and veterinary applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Hayward, California.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Phone510-906-4600
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees33
OptionableOptionable
Pulse Biosciences (NASDAQ:PLSE) Frequently Asked Questions
What is Pulse Biosciences' stock symbol?
Pulse Biosciences trades on the NASDAQ under the ticker symbol "PLSE."
How were Pulse Biosciences' earnings last quarter?
Pulse Biosciences Inc (NASDAQ:PLSE) released its quarterly earnings results on Thursday, February, 7th. The company reported ($0.51) earnings per share for the quarter. View Pulse Biosciences' Earnings History.
When is Pulse Biosciences' next earnings date?
Has Pulse Biosciences been receiving favorable news coverage?
News stories about PLSE stock have trended somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Pulse Biosciences earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.
Who are some of Pulse Biosciences' key competitors?
Some companies that are related to Pulse Biosciences include Atrion (ATRI), Nevro (NVRO), Tactile Systems Technology (TCMD), AtriCure (ATRC), Orthofix Medical (OFIX), K2M Group (KTWO), Luminex (LMNX), Cardiovascular Systems (CSII), Intersect ENT (XENT), Cryolife (CRY), Cerus (CERS), AngioDynamics (ANGO), SurModics (SRDX), OraSure Technologies (OSUR) and Anika Therapeutics (ANIK).
Who are Pulse Biosciences' key executives?
Pulse Biosciences' management team includes the folowing people:
- Mr. Darrin R. Uecker, Pres, CEO & Director (Age 52)
- Mr. Brian B. Dow, CFO, Sr. VP of Fin. & Admin., Treasurer and Sec. (Age 49)
- Dr. Richard Nuccitelli Ph.D., Chief Science Officer
- Dr. Holly Hartman Ph.D., J.D., VP of Bus. Devel. & Corp. Strategy
- Mr. David Danitz, VP of Engineering
When did Pulse Biosciences IPO?
(PLSE) raised $20 million in an IPO on Wednesday, May 18th 2016. The company issued 5,000,000 shares at a price of $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO.
Who are Pulse Biosciences' major shareholders?
Pulse Biosciences' stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (2.98%), Northern Trust Corp (0.59%), Geode Capital Management LLC (0.57%), Bank of New York Mellon Corp (0.28%), Bank of America Corp DE (0.10%) and Westside Investment Management Inc. (0.09%). Company insiders that own Pulse Biosciences stock include Maky Zanganeh, Mitchell E Levinson, Robert J Greenberg, Robert W Duggan and Thierry B Thaure. View Institutional Ownership Trends for Pulse Biosciences.
Which major investors are selling Pulse Biosciences stock?
Which major investors are buying Pulse Biosciences stock?
PLSE stock was bought by a variety of institutional investors in the last quarter, including Geode Capital Management LLC, Rhumbline Advisers and Northern Trust Corp. Company insiders that have bought Pulse Biosciences stock in the last two years include Maky Zanganeh, Mitchell E Levinson and Robert W Duggan. View Insider Buying and Selling for Pulse Biosciences.
How do I buy shares of Pulse Biosciences?
Shares of PLSE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Pulse Biosciences' stock price today?
One share of PLSE stock can currently be purchased for approximately $16.39.
How big of a company is Pulse Biosciences?
Pulse Biosciences has a market capitalization of $337.29 million. Pulse Biosciences employs 33 workers across the globe.
What is Pulse Biosciences' official website?
How can I contact Pulse Biosciences?
Pulse Biosciences' mailing address is 3957 POINT EDEN WAY, HAYWARD CA, 94545. The company can be reached via phone at 510-906-4600 or via email at [email protected]
MarketBeat Community Rating for Pulse Biosciences (NASDAQ PLSE)
MarketBeat's community ratings are surveys of what our community members think about Pulse Biosciences and other stocks. Vote "Outperform" if you believe PLSE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PLSE will underperform the S&P 500 over the long term. You may vote once every thirty days.
